Bothell Biopharmaceutical Company Pays $4 Million To Resolve Allegations It Relied On Falsified Academic Papers To Obtain Federal Grant

Bothell Biopharmaceutical Company Pays $4 Million To Resolve Allegations It Relied On Falsified Academic Papers To Obtain Federal Grant

CEO resigned after her doctoral work was found to have falsified and manipulated images

Seattle - A Bothell, Washington, pharmaceutical company will pay $4,068,698 to resolve allegations it used falsified academic research to obtain grants from the National Institute of Health (NIH), announced U.S. Attorney Tessa M. Gorman. The research studies in question were into age-related cognitive decline such as Alzheimer's. However, when the company applied for a federal grant, it failed to notify NIH of allegations that its former Chief Executive Officer (CEO) committed research misconduct when she falsified images from her doctoral dissertation. The allegations were called to the government's attention through a qui tam lawsuit. The relator will receive a portion of the payment for uncovering the fraud.

Read more on www.justice.gov

Share